Literature DB >> 23162969

There may be a role for hyperbaric oxygen therapy in transient osteoporosis of the hip.

Mesut Mutluoglu1, Guner Sonmez, Ali Kemal Sivrioglu, Hakan Ay.   

Abstract

Transient osteoporosis of the hip (TOH) is a rare clinical condition with usually an unknown aetiology and which typically develops in middle-aged men, or in women in the third trimester of their pregnancy. It is characterized by transient osteopenia and by gradually increasing pain associated with a limitation of the range of motion of the hip. Bone marrow oedema is a typical but nonspecific finding in TOH. A 33-year-old female patient presented with severe hip pain one month after delivery. Her history was unremarkable except for a Hashimoto's Disease of 8 years' duration. Magnetic resonance imaging (MRI) showed significant bone marrow oedema with increased signal intensity in the femoral head on T2-weighted images. A diagnosis of TOH was made and the patient received a total of 30 sessions of hyperbaric oxygen (HBO) at 2.4 ATA, 2 hours each, in a multiplace chamber. Over the course of HBO treatment, her pain was gradually relieved and she became asymptomatic after one month together with a complete recovery of the range of motion of the hip. MRI of the hips 10 weeks after onset of HBO therapy showed normal signal intensity on T2-weighted images.

Entities:  

Mesh:

Year:  2012        PMID: 23162969

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  4 in total

Review 1.  Transient osteoporosis of the hip: review of the literature.

Authors:  K Asadipooya; L Graves; L W Greene
Journal:  Osteoporos Int       Date:  2017-03-17       Impact factor: 4.507

2.  Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients.

Authors:  Giuliano Vezzani; Silvia Quartesan; Pasqua Cancellara; Enrico Camporesi; Devanand Mangar; Thomas Bernasek; Prachiti Dalvi; Zhongjin Yang; Antonio Paoli; Alex Rizzato; Gerardo Bosco
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  Transient Osteoporosis of the Hip: Risk and Therapy.

Authors:  Khaldoon M Bashaireh; Fa'ek M Aldarwish; Ali A Al-Omari; Moath A Albashaireh; Mai Hajjat; Mohammad A Al-Ebbini; Abdelwahab J Aleshawi
Journal:  Open Access Rheumatol       Date:  2020-01-09

4.  Extracorporeal shock wave therapy in the treatment of primary bone marrow edema syndrome of the knee: a prospective randomised controlled study.

Authors:  Fuqiang Gao; Wei Sun; Zirong Li; Wanshou Guo; Weiguo Wang; Liming Cheng; Debo Yue; Nianfei Zhang; Amanda Savarin
Journal:  BMC Musculoskelet Disord       Date:  2015-12-05       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.